{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:30:57Z","timestamp":1794047457781,"version":"4.8.0"},"reference-count":15,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"5","license":[{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"DOI":"10.3324\/haematol.2023.283944","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T14:31:00Z","timestamp":1704292260000},"page":"1576-1581","source":"Crossref","is-referenced-by-count":2,"title":["Acute myeloid leukemia-driven IL-3-dependent upregulation of BCL2 in non-malignant hematopoietic stem and progenitor cells increases venetoclax-induced cytopenias"],"prefix":"10.3324","volume":"109","author":[{"given":"Dominic J.","family":"Fowler-Shorten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca S.","family":"Maynard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Hampton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Altera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Markham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Ehikioya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edyta E.","family":"Wojtowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian M.","family":"Bowles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart A.","family":"Rushworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Hellmich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2024,1,4]]},"reference":[{"key":"60967","doi-asserted-by":"crossref","unstructured":"DiNardo CD, Pratz K, Pullarkat V. Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia. Blood. 2019; 133(1):7-17.","DOI":"10.1182\/blood-2018-08-868752"},{"key":"60968","doi-asserted-by":"crossref","unstructured":"Wei AH, Montesinos P, Ivanov V. Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial. Blood. 2020; 135(24):2137-2145.","DOI":"10.1182\/blood.2020004856"},{"key":"60969","doi-asserted-by":"crossref","unstructured":"Wang ES. Treating acute myeloid leukemia in older adults. Hematology Am Soc Hematol Educ Program. 2014; 2014(1):14-20.","DOI":"10.1182\/asheducation-2014.1.14"},{"key":"60970","doi-asserted-by":"crossref","unstructured":"Almeida AM, Ramos F. Acute myeloid leukemia in the older adults. Leuk Res Rep. 2016; 6:1-7.","DOI":"10.1016\/j.lrr.2016.06.001"},{"key":"60971","doi-asserted-by":"crossref","unstructured":"Dennis M, Copland M, Kaur H. Management of older patients with frailty and acute myeloid leukaemia: a British Society for Haematology good practice paper. Br J Haematol. 2022; 199(2):205-221.","DOI":"10.1111\/bjh.18369"},{"key":"60972","doi-asserted-by":"crossref","unstructured":"DiNardo CD, Jonas BA, Pullarkat V. Azacitidine and venetoclax in previously untreated acute myeloid leukemia. N Engl J Med. 2020; 383(7):617-629.","DOI":"10.1056\/NEJMoa2012971"},{"key":"60973","doi-asserted-by":"crossref","unstructured":"Abdul-Aziz AM, Sun Y, Hellmich C. Acute myeloid leukemia induces protumoral p16INK4a-driven senescence in the bone marrow microenvironment. Blood. 2019; 133(5):446-456.","DOI":"10.1182\/blood-2018-04-845420"},{"key":"60974","doi-asserted-by":"crossref","unstructured":"Moore JA, Mistry JJ, Hellmich C. LC3-associated phagocytosis in bone marrow macrophages suppresses acute myeloid leukemia progression through STING activation. J Clin Invest. 2022; 132(5):1-16.","DOI":"10.1172\/JCI153157"},{"key":"60975","doi-asserted-by":"crossref","unstructured":"Simonart T, Van Vooren JP. Interleukin-1 beta increases the BCL-2\/BAX ratio in Kaposi\u2019s sarcoma cells. Cytokine. 2002; 19(6):259-266.","DOI":"10.1006\/cyto.2002.1964"},{"key":"60976","doi-asserted-by":"crossref","unstructured":"Rinaudo MS, Su K, Falk LA, Halder S, Mufson RA. Human interleukin-3 receptor modulates bcl-2 mRNA and protein levels through protein kinase C in TF-1 cells. Blood. 1995; 86(1):80-88.","DOI":"10.1182\/blood.V86.1.80.bloodjournal86180"},{"key":"60977","doi-asserted-by":"crossref","unstructured":"Sepulveda P, Encabo A, Carbonell-Uberos F, Minana MD. BCL-2 expression is mainly regulated by JAK\/STAT3 pathway in human CD34+ hematopoietic cells. Cell Death Differ. 2007; 14(2):378-380.","DOI":"10.1038\/sj.cdd.4402007"},{"key":"60978","doi-asserted-by":"crossref","unstructured":"Genestier L, Bonnefoy-Berard N, Rouault JP, Flacher M, Revillard JP. Tumor necrosis factor-alpha up-regulates Bcl-2 expression and decreases calcium-dependent apoptosis in human B cell lines. Int Immunol. 1995; 7(4):533-540.","DOI":"10.1093\/intimm\/7.4.533"},{"key":"60979","doi-asserted-by":"crossref","unstructured":"Elbaz O, Shaltout A. Implication of granulocyte-macrophage colony stimulating factor (GM-CSF) and interleukin-3 (IL-3) in children with acute myeloid leukaemia (AML); malignancy. Hematology. 2001; 5(5):383-388.","DOI":"10.1080\/10245332.2000.11746533"},{"key":"60980","doi-asserted-by":"crossref","unstructured":"Nitsche A, Junghahn I, Thulke S. Interleukin-3 promotes proliferation and differentiation of human hematopoietic stem cells but reduces their repopulation potential in NOD\/SCID mice. Stem Cells. 2003; 21(2):236-244.","DOI":"10.1634\/stemcells.21-2-236"},{"key":"60981","doi-asserted-by":"crossref","unstructured":"Tajer P, Cante-Barrett K, Naber BAE. IL3 has a detrimental effect on hematopoietic stem cell self-renewal in transplantation settings. Int J Mol Sci. 2022; 23(21):1-8.","DOI":"10.3390\/ijms232112736"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.283944\/76487","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.283944\/76952","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11392\/76487","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:05:29Z","timestamp":1794045929000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2023.283944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,4]]},"references-count":15,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2023.283944","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,4]]}}}